Clinical trial
A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of…
NCT00254566 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00254566 |
|---|---|
| Title | A Trial To Evaluate Two Antibiotics For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB) |
| Official title | A Phase 3B Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial To Evaluate The Efficacy and Safety Of Azithromycin SR (Microspheres Formulation) Versus Moxifloxacin For The Treatment Of Acute Exacerbation Of Chronic Bronchitis (AECB). |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Bronchitis |
| Intervention type | Drug, Other |
| Interventions | Moxifloxacin Placebo, Moxifloxacin, Azithromycin SR Placebo, Azithromycin SR |
| Enrollment | 398 |
| Start date | Feb 1, 2006 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Nov 16, 2005 |
| Last update posted | Nov 11, 2009 |
| Countries | China, Malaysia, Philippines, Singapore, Taiwan, Thailand |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: